Regarding CCH-induced neurodegeneration, evidence from preclinical studies demonstrated that inhibition of IDO is protective against neuroinflammation in Parkinson’s disease, Alzheimer’s disease, and depression [83,84,85]. The gene discussed is IDO1; the disease is early-onset autosomal dominant Alzheimer disease.